MINNEAPOLIS, March 22, 2016 -- Charles H. Johnson & Associates announces that it has begun an investigation into the proposed merger/inversion between Johnson Controls Inc. (“JCI”) and Tyco International plc (“Tyco”), as announced on January 25, 2016, in connection with which JCI proposes to move its corporate domicile from Wisconsin to Ireland.
The combination is to be structured as a “tax inversion” to substantially lower JCI’s tax rate on its foreign earnings by replacing the U.S. tax rates to which its foreign earnings are subject with the much lower Irish tax rate.
JCI stated in its January 25th announcement that the exchange of JCI common stock for Tyco ordinary shares will be taxable to JCI shareholders, as the merger will be considered a sale of their shares rather than a tax-free exchange as is typically the case in such transactions. If the proposed combination is approved by JCI shareholders and consummated, many JCI shareholders who have held their stock for more than a year will be forced to pay federal taxes at rates of 15% to 30% on their gains, in addition to state taxes.
The investigation is looking into whether the JCI Board of Directors is adequately representing the interests of JCI’s shareholders in connection with the Tyco acquisition and, if not, whether such failure may constitute a breach of fiduciary duty by the JCI Board of Directors and whether JCI or others may be aiding and abetting such breach or violating other laws.
If you hold JCI stock and believe that you may be subject to capital gains or other taxes due to the Tyco acquisition, or have any questions concerning this notice or your rights with respect to this matter, please contact:
Jonathan R. Mencel, Esq. ([email protected])
Law Offices of Charles H. Johnson, P.A.
2599 Mississippi Street
New Brighton, MN 55112
(651) 633-5685


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Italy Fines Apple €98.6 Million Over App Store Dominance
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 



